NASDAQ · Shell Companies · USD

Research Alliance Corporation IV (RACD) Stock Analysis

Research Alliance Corporation IV (RACD) is a Shell Companies stock listed on NASDAQ and quoted in US Dollar.

RACD

$12.05

−$0.45 (−3.56%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare RACD with… →

RACD Key Statistics

As of Sep 4, 2026

Trading

Open: $12.00
Previous Close: $12.49
Day's Range: 12.00–12.48
52-Week Range: 10.00–13.64
Volume: 3.38K

Valuation

Market Cap: $109.59M

Financials (FY)

Profit margin: 0.00%
Shares Outstanding: 7.78M

Dividend and dates

Avg Volume: 24.29K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

RACD Valuation vs Shell Companies Median

Median of 325 stocks

Metric	RACD	Shell Companies median	vs median
Profit margin	0.00%	0.00%	0.0 pts above

Medians across 325 Shell Companies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

The market values Research Alliance Corporation IV (RACD) at $109.59M. It is classified in the Shell Companies industry, within the Financial Services sector.

Over the past 52 weeks the price has ranged from $10.00 to $13.64. The most recent close on file for RACD is $12.05, dated September 4, 2026. That is −$0.45 (−3.56%) against the previous close. The latest close sits 20.45% above that 52-week low.

Financial Health

The reported profit margin is 0%.

Growth & Income

No dividend is on file for RACD.

2026 is still running; the price is +16.49% year to date.

Peer Comparison

Research Alliance Corporation IV (RACD) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Research Alliance Corporation IV	RACD	$109.59M	—
Churchill Capital Corp XI	CCXI	$746.38M	—
Churchill Capital Corp X	CCCX	$711.00M	—
Drugs Made In America Acquisition II Corp.	DMII	$647.83M	35.1

The Shell Companies industry average P/E ratio is 45.2x. Research Alliance Corporation IV has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Shell Companies Stocks

CCXI

Churchill Capital Corp XI

$746.38M

CCCX

Churchill Capital Corp X

$711.00M

DMII

Drugs Made In America Acquisition II Corp.

$647.83M

BCSS

Bain Capital GSS Investment Corp.

$602.40M

EVAC

EQV Ventures Acquisition Corp. II

$602.01M

CXII

Churchill Capital Corp XII

$594.94M

View all Shell Companies stocks →

Popular Financial Services Stocks

BRK-B

Berkshire Hathaway Inc.

$1.08T

JPM

JPMorgan Chase & Co.

$953.33B

Visa Inc.

$700.27B

Mastercard Incorporated

$507.39B

BAC

Bank of America Corporation

$438.31B

View all Financial Services stocks →

About Research Alliance Corporation IV

Research Alliance Corporation IV does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, or other similar business combination. The company was incorporated in 2026 and is based in New York, New York.